$0 is the total value of Sonic Fund II, L.P.'s 1 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | n/an/a | $0 | – | 0 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES INC | 12 | Q3 2022 | 47.8% |
| GENWORTH FINL INC | 12 | Q3 2022 | 14.5% |
| FENNEC PHARMACEUTICALS INC | 12 | Q3 2022 | 13.2% |
| REGENXBIO INC | 12 | Q3 2022 | 19.6% |
| TRONOX HOLDINGS PLC | 12 | Q3 2022 | 3.3% |
| SPIRIT AIRLS INC | 11 | Q3 2022 | 8.7% |
| US FOODS HLDG CORP | 11 | Q3 2022 | 7.7% |
| RADIAN GROUP INC | 11 | Q3 2022 | 4.1% |
| HAWAIIAN HOLDINGS INC | 11 | Q3 2022 | 4.5% |
| UNITED AIRLS HLDGS INC | 10 | Q3 2022 | 4.9% |
View Sonic Fund II, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc. | December 30, 2022 | 4,552,068 | 4.6% |
| FENNEC PHARMACEUTICALS INC. | February 14, 2022 | 2,407,357 | 9.3% |
View Sonic Fund II, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2022-12-30 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Sonic Fund II, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.